Nisa Investment Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
Nisa Investment Advisors's ARCT Position: Q2 2026 in Review
Nisa Investment Advisors opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 3,300 shares worth $22.2K. The stake represents ﹤0.01% of the portfolio and ranks #2176 among its holdings. This is a return to the name: Nisa Investment Advisors previously reported a position in ARCT as recently as Q3 2025.
Nisa Investment Advisors first reported a position in ARCT in Q4 2020 and has held it in 21 quarters since. The position peaked at $57K in Q3 2021. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.
- Nisa Investment Advisors held 3,300 shares of Arcturus Therapeutics worth $22.2K as of Q2 2026.
- Arcturus Therapeutics was a new Nisa Investment Advisors position in Q2 2026.
- Arcturus Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2176 holding.
- Nisa Investment Advisors first reported a position in Arcturus Therapeutics in Q4 2020 and has held it in 21 quarters since.
- Nisa Investment Advisors's Arcturus Therapeutics position peaked at $57K in Q3 2021.
- 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.